Alerts will be sent to your verified email
Verify Email
IPCALAB
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
IPCA Laboratories Limited is a pharmaceutical company founded in 1949, with a global presence in manufacturing and marketing various formulations and APIs across different therapeutic segments. It is a leading supplier of APIs worldwide.
Ipca Laboratories major competitors are Ajanta Pharma, Gland Pharma, JB Chem & Pharma, Eris Lifesciences, Pfizer, Wockhardt, Glaxosmithkline Phar.
Market Cap of Ipca Laboratories is ₹34,652 Crs.
While the median market cap of its peers are ₹26,995 Crs.
Ipca Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Ipca Laboratories is 6.6 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | Mar | Jun | Sep Dec | ||||||||
| Investor Presentation | Mar | Jun Dec | Jun Sep Dec | Dec | Jun Dec | |||||||||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep Dec | Sep Dec | Dec | Sep | |||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
